CDx® Media and Press Releases

New Data Demonstrate That WATS3D Is 4X More Effective Than the Seattle Random Biopsy Protocol in the Detection of High-Grade Dysplasia and Esophageal Adenocarcinoma - Results From a Pivotal Prospective Randomized Crossover Study Conducted at 14 Major Academic Gastroenterology Centers to Be Presented at Digestive Disease Week

May 21, 2016
Read more >




WATS3D Three Dimensional Computer-Assisted Biopsy Analysis Demonstrates Exceptionally High Inter-Observer Agreement in the Evaluation of Esophageal Pre-Cancers - New Study Results Published in the American Journal of Gastroenterology

September 10, 2015
Read more >




WATS3D Biopsy Increases Detection of Barrett's Esophagus by 68.4% and Esophageal Dysplasia by 64.7% in Largest Study to Date - Results of a Study of Over 2,500 Patients Who Received EGD in Community-Based Settings Highlighted in the Presidential Plenary Session at Digestive Disease Week

May 05, 2014
Read more >




New Study Confirms High Inter-Observer Agreement Using the WATS3D Biopsy for Evaluation of Esophageal Pre-Cancer - Provides Powerful Validation for the Clinical Value of Using the WATS3D Procedure as a Complement to Four Quadrant Biopsy; Results Highlighted in an Oral Presentation at Digestive Disease Week

May 4, 2014
Read more >




Study Shows WATS3D Biopsy Increases Detection of Pre-Cancer in the Esophagus by 50% in Post-Ablation Patients - Data Underscores Value of Using WATS3D as a Surveillance Tool for Residual or Recurrent Pre-Cancer

October 14, 2013
Read more >




CDx Diagnostics to Highlight Groundbreaking New WATS3D Data at the American College of Gastroenterology Annual Scientific Meeting - First Study Evaluating the WATS3D Biopsy for the Detection of Biliary Tract Cancer | Two Studies Reinforcing the Value of WATS3D for Surveillance of Esophageal Pre-Cancer

October 10, 2013
Read more >




New Data Reinforce the Value of the CDx Diagnostics' WATS3D Biopsy in Detecting Otherwise Hidden Precancer of the Esophagus - Multicenter Study Confirms Earlier Research Showing That a Unique "Wide Area Biopsy" Analyzed by 3D Imaging Algorithms Originally Developed for Missile Defense, Can Help to Defend Patients Against Undetected Precancerous Disease

May 19, 2013
Read more >




Two New Studies Show CDx Diagnostics' WATS3D Esophageal Biopsy Increases Detection of Residual and Recurrent Barrett's Esophagus and Dysplasia in Post-Ablation Patients - Adjunctive Use of WATS3D Improves Detection of Residual Barrett's Esophagus Missed by Random Forceps Biopsy Surveillance

May 20, 2013
Read more >




Oral Cancer Prevention International and CDx Laboratories Merge to Form CDx Diagnostics - New Company to Market Innovative Diagnostic Tools That Enable Prevention and Earlier Detection of Oral, Laryngeal and Esophageal Cancers Strong Pipeline of New Tests for Liver, Pancreatic and Colon Cancer Will Create Additional Value

January 8, 2013
Read more >




CDx Diagnostics Announces Live Demonstration Series of the New WATS3D Biopsy at DDW 2012 - Computer-Aided Diagnostic System Shown to Increase Detection of Barrett's and Dysplasia by up to 40%

May 17, 2012
Read more >




New Data Confirm Value of CDx Diagnostics' WATS3D Biopsy in Detecting Residual Precancerous Tissue Following Ablation for Barrett's Esophagus - Data Presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting

Oct 22, 2012
Read more >




Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent - Studies Confirm an Important Advance Against the Most Rapidly Growing Cancer in the U.S.

May 19, 2011
Read more >




Brush Biopsy Plus Forceps Biopsy Increase Detection of Barrett's Esophagus and Dysplasia, Two Studies Report

Gastroenterology & Endoscopy News, May 2011
Read more >




New Method for Detection of Precancerous Cells in Heartburn Patients Can Help to Prevent Esophageal Adenocarcinoma, the Most Rapidly Growing Form of Cancer in the U.S.

March 24, 2011
Read more >




For general corporate information and background, please visit the other on-line resources listed below.
Executive Team | CDx Technology | Clinical Studies | Video Library

If you are not a member of the media, please submit your inquiry on our Contact Us page. Every effort will be made to respond to your request in a timely manner.